Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth H Rand

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
The Journal of Antimicrobial Chemotherapy|February 14, 2004
Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococciKenneth H Rand, Herbert Houck
American Journal of Clinical Pathology|October 20, 2006
Errors in interpretation of Gram stains from positive blood culturesKenneth H Rand, Maria Tillan
Antimicrobial Agents and Chemotherapy|July 27, 2004
Synergy of daptomycin with oxacillin and other beta-lactams against methicillin-resistant Staphylococcus aureusKenneth H Rand, Herbert J Houck
Journal of Clinical Microbiology|October 11, 2008
Evaluation of repeat Clostridium difficile enzyme immunoassay testingDiana M Cardona, Kenneth H Rand
Diagnostic Microbiology and Infectious Disease|April 29, 2014
Direct identification of bacteria in positive blood cultures: comparison of two rapid methods, FilmArray and mass spectrometryKenneth H Rand, John P Delano
Expert Review of Molecular Diagnostics|December 23, 2015
Sample-to-result molecular infectious disease assays: clinical implications, limitations and potentialStacy G Beal, Naziheh Assarzadegan, Kenneth H Rand
Journal of Clinical Microbiology|April 22, 2011
Comparison of two multiplex methods for detection of respiratory viruses: FilmArray RP and xTAG RVPKenneth H Rand, Howard Rampersaud, Herbert J Houck
International Journal of Antimicrobial Agents|March 6, 2009
Ceftobiprole: a novel cephalosporin with activity against Gram-positive and Gram-negative pathogens, including methicillin-resistant Staphylococcus aureus (MRSA)April Barbour, Stephan Schmidt, Kenneth H Rand, et al.
Diagnostic Microbiology and Infectious Disease|September 11, 2017
Relationship between bacteriology report time in the morning and length of stay in hospital after the reportKenneth H Rand, Stacy G Beal, Gloria P Lipori
International Journal of Antimicrobial Agents|January 25, 2005
Pharmacokinetic-pharmacodynamic modelling of antibacterial activity of cefpodoxime and cefixime in in vitro kinetic modelsPing Liu, Kenneth H Rand, Bernd Obermann, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
The Journal of Antimicrobial Chemotherapy|February 14, 2004
Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococciKenneth H Rand, Herbert Houck
American Journal of Clinical Pathology|October 20, 2006
Errors in interpretation of Gram stains from positive blood culturesKenneth H Rand, Maria Tillan
Antimicrobial Agents and Chemotherapy|July 27, 2004
Synergy of daptomycin with oxacillin and other beta-lactams against methicillin-resistant Staphylococcus aureusKenneth H Rand, Herbert J Houck
Journal of Clinical Microbiology|October 11, 2008
Evaluation of repeat Clostridium difficile enzyme immunoassay testingDiana M Cardona, Kenneth H Rand
Diagnostic Microbiology and Infectious Disease|April 29, 2014
Direct identification of bacteria in positive blood cultures: comparison of two rapid methods, FilmArray and mass spectrometryKenneth H Rand, John P Delano
Expert Review of Molecular Diagnostics|December 23, 2015
Sample-to-result molecular infectious disease assays: clinical implications, limitations and potentialStacy G Beal, Naziheh Assarzadegan, Kenneth H Rand
Journal of Clinical Microbiology|April 22, 2011
Comparison of two multiplex methods for detection of respiratory viruses: FilmArray RP and xTAG RVPKenneth H Rand, Howard Rampersaud, Herbert J Houck
International Journal of Antimicrobial Agents|March 6, 2009
Ceftobiprole: a novel cephalosporin with activity against Gram-positive and Gram-negative pathogens, including methicillin-resistant Staphylococcus aureus (MRSA)April Barbour, Stephan Schmidt, Kenneth H Rand, et al.
Diagnostic Microbiology and Infectious Disease|September 11, 2017
Relationship between bacteriology report time in the morning and length of stay in hospital after the reportKenneth H Rand, Stacy G Beal, Gloria P Lipori
International Journal of Antimicrobial Agents|January 25, 2005
Pharmacokinetic-pharmacodynamic modelling of antibacterial activity of cefpodoxime and cefixime in in vitro kinetic modelsPing Liu, Kenneth H Rand, Bernd Obermann, et al.
Pageof 5